Net Impact (CE) (USOTC:NTHD)
Historical Stock Chart
From Jan 2020 to Jan 2025
NetImpact Holdings Signs Professional Services Teaming Agreement
With Alkemiya
LAS VEGAS, April 7 /PRNewswire-FirstCall/ -- NetImpact Holdings, Inc. (OTC Pink
Sheets: NTHD) today announced that it has signed a Professional Services Teaming
Agreement with Alkemiya L.L.C., an Alkemiya Group company. Alkemiya is an
international communications, education and business development professional
partnership with offices in the United States and England. Alkemiya and its
associates have senior-level relationships and ongoing business programs in more
than 20 African, Sub-Continent, European and Latin American countries. Because
these countries have a stated need for healthcare services and products, the
Teaming agreement was signed so Alkemiya and its associates can approach these
countries presenting NetImpact's healthcare capabilities as a solution to many
of their healthcare needs. Alkemiya will benefit from contracts awarded to
NetImpact because under the Teaming agreement they will be the exclusive
provider of all communications installation, maintenance and management of the
networks and services related to supporting the transfer of healthcare data as
well as providing associated training and distance learning services.
Alkemiya and its associates have access to entities that have funds for
healthcare programs that target developing countries. Alkemiya believes that
through this plan they will have a very good chance of obtaining additional
contract funding for the Team's initiatives.
"Entering into this relationship with Alkemiya provides the opportunity for both
companies to increase their respective business base from contracts awarded to
NetImpact," NetImpact stated. "Healthcare is a cornerstone for the economic
development of any country. The implementation of these healthcare programs
requires significant communications networks and teaming as part of the overall
deployment."
"Because Alkemiya and its associates are currently working in target developing
countries and have existing relations with the governments and Ministries, we
will approach the appropriate government officials to jointly conduct assessment
studies of their healthcare needs, the support communication infrastructure and
distance and e-learning requirements," Alkemiya stated. "Utilizing Alkemiya's
and its associates' strengths and our excellent resources, the chances for
success of the Team are much greater."
NetImpact will focus on establishing a "Healthcare Infrastructure" utilizing
NetCare7.0, its patented software and operating system, to manage the
collection, analysis and dissemination of healthcare data between the various
healthcare facilities. The governments through the Ministries of Health will
have the information to deliver and improve the delivery of care. Once started,
NetImpact will pursue additional funding to provide its patented and licensed
MDS 200 disease detections systems to these countries.
The MDS200 lab-in-a-box is a breakthrough technology for disease detection.
Currently it is capable of automatic preparation and testing of samples
containing cell, protein, nucleic acid and chemical analytes. The MDS200 can be
deployed as a P.C.-based system or as a small suitcase size ruggedized portable
laboratory designed for use in remote areas with non- existent or scarce
laboratory facilities and readily carried from location to location. Test
results are displayed on the unit's LED and can be sent via satellite, wireless
or dial-up connections. Once a samplehas been placed in the lab-in-a-box, the
processing is spontaneous. While operating an MDS200 does not require a trained
medical technician, the program will create hundreds of jobs for training of
in-country personnel. This jobs training program, as provided by Alkemiya, will
be a key requirement that will ensure that the long-term program objectives will
be met and that real benefits are provided to every country that implements the
NetImpact healthcare program.
About NetImpact Holdings, Inc.
NetImpact Holdings, Inc. is a technology-to-market company focusing on the
installation, restructuring and management of global healthcare and medical
delivery systems. Through acquisitions and extensive access to
international/U.S. distribution networks,NetImpact specializes in presenting
technology that will assist in the improvement of productivity, applications
development, and technology transfer in developing countries. The Company's
NetCare Division, Medical and Diagnostic Devices Division, andNeurowave
Division are moving their technologies, products and services to an awaiting
market.
Safe Harbor Statement
The statements in this release that are not historical facts are forward-
looking statements within the meaning of Section 27A of theSecurities Act of
1933 and Section 21E of the Securities Exchange Act of 1934. NetImpact Holdings,
Inc. intends that such forward-looking statements be subject to the safe harbors
created thereby. These forward-looking statements include predictions, estimates
and other statements that involve a number of risks and uncertainties any, or
all, of which could cause actual results to differ materially from any future
performance suggested herein. While this outlook represents NetImpact Holdings,
Inc.'s current judgment on the future direction of the business, such risks and
uncertainties may individually, or mutually, impact the matters herein
described, including but not limited to, product acceptance, the economy,
competition, governmental actions, results of litigation, technological and/or
other factors, which are outside the control of NetImpact Holdings, Inc. as well
as those risks and uncertainties detailed in the Company's Security and Exchange
Commission filings.
CONTACT
Alkemiya - Phil Martin
561-881-7318
NetImpact - Rod Felton
702-255-6443
DATASOURCE: NetImpact Holdings, Inc.
CONTACT: Phil Martin, Alkemiya, +1-561-881-7318; or Rod Felton,
NetImpact, +1-702-255-6443
Web site: http://www.netimpact.com/